Literature DB >> 6967256

Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae: their occurrence and course in children with cancer.

G R Siber.   

Abstract

Nine Haemophilus influenzae and 24 Streptococcus pneumoniae bacteremias occurring in children with cancer during the years 1968 to 1977 were reviewed. The number of bacteremias due to these organisms remained relatively constant, in contrast with a sharp decrease in bacteremias caused by other organisms during this period. The highest incidence of bacteremia occurred in patients with acute leukemias and the lowest incidence in patients with solid tumors. Twenty-seven of 33 episodes occurred while patients were receiving chemotherapy. Nine bacteremias were fatal, but concurrent or superinfections contributed to death in six of these. Children with cancer who are receiving chemotherapy seem to be at higher risk of bacteremia and meningitis due to H influenzae and Strep pneumoniae than are normal children. New approaches to the prevention of these infections, such as the use of bacterial polysaccharide vaccines, deserve investigation.

Entities:  

Mesh:

Year:  1980        PMID: 6967256     DOI: 10.1001/archpedi.1980.02130190036009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  3 in total

1.  Statement on Haemophilus influenzae type b polysaccharide vaccine.

Authors: 
Journal:  CMAJ       Date:  1986-06-15       Impact factor: 8.262

2.  Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.

Authors:  G R Siber; D M Ambrosino; J McIver; T J Ervin; G Schiffman; S Sallan; G F Grady
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancer.

Authors:  Nicola Principi; Valentina Preti; Stefania Gaspari; Antonella Colombini; Marco Zecca; Leonardo Terranova; Maria Giuseppina Cefalo; Valentina Ierardi; Claudio Pelucchi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.